Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.7 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |